Butanedione treatment reduces receptor binding of a lysosomal enzyme to cells and membranes.
D000818:Animals; D002074:Butanones / Q000494:pharmacology*; D002462:Cell Membrane / Q000378:metabolism; D002478:Cells, Cultured; D002813:Chondrosarcoma / Q000378:metabolism; D003931:Diacetyl / Q000494:pharmacology*; D005347:Fibroblasts / Q000378:metabolism; D006026:Glycoside Hydrolases / Q000378:metabolism*; D006801:Humans; D007068:Iduronidase / Q000172:deficiency / Q000378:metabolism*; D007700:Kinetics; D008247:Lysosomes / Q000201:enzymology; D009374:Neoplasms, Experimental / Q000378:metabolism; D011485:Protein Binding; D051381:Rats; D011955:Receptors, Drug / Q000378:metabolism*
D002074:Butanones; D011955:Receptors, Drug; D006026:Glycoside Hydrolases; D007068:Iduronidase; D003931:Diacetyl